Market icon

Flu Hospitalization Rate Week 12, 2026?

Market icon

Flu Hospitalization Rate Week 12, 2026?

Mar 27

Apr 3

Mar 27

Apr 3

90–95 10%

95+ 9.8%

85–90 5.5%

<75 2.5%

Polymarket
NEW

90–95 10%

95+ 9.8%

85–90 5.5%

<75 2.5%

Polymarket
NEW

<75

$145 Vol.

2%

75–80

$171 Vol.

19%

80–85

$327 Vol.

61%

85–90

$158 Vol.

24%

90–95

$2,983 Vol.

10%

95+

$110 Vol.

10%

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Trader consensus on Polymarket strongly favors a cumulative flu hospitalization rate of 80–85 per 100,000 population through week 12 (late March) 2026 at 68% implied probability, aligning closely with the median from CDC FluSurv-NET historical data across moderate seasons since 2010, where rates typically range 70–90 by mid-March amid waning winter peaks. This positioning reflects stable epidemiological baselines, with annual severity driven by influenza strain dominance—often A(H3N2)—vaccine matching, and population immunity levels, rather than short-term anomalies. The ongoing 2024–25 season's hospitalization rate has declined sharply to under 2 per 100,000 weekly (cumulative ~50), marking a mild year consistent with good vaccine efficacy but underscoring yearly variability; no major shifts like novel variants have emerged in recent CDC surveillance to alter 2026 forecasts. Watch for WHO's September 2025 northern hemisphere vaccine strain recommendations, which could signal mismatch risks influencing transmission dynamics.

Trader consensus on Polymarket strongly favors a cumulative flu hospitalization rate of 80–85 per 100,000 population through week 12 (late March) 2026 at 68% implied probability, aligning closely with the median from CDC FluSurv-NET historical data across moderate seasons since 2010, where rates typically range 70–90 by mid-March amid waning winter peaks. This positioning reflects stable epidemiological baselines, with annual severity driven by influenza strain dominance—often A(H3N2)—vaccine matching, and population immunity levels, rather than short-term anomalies. The ongoing 2024–25 season's hospitalization rate has declined sharply to under 2 per 100,000 weekly (cumulative ~50), marking a mild year consistent with good vaccine efficacy but underscoring yearly variability; no major shifts like novel variants have emerged in recent CDC surveillance to alter 2026 forecasts. Watch for WHO's September 2025 northern hemisphere vaccine strain recommendations, which could signal mismatch risks influencing transmission dynamics.

Resumen experimental generado por IA con datos de Polymarket · Actualizado
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Trader consensus on Polymarket strongly favors a cumulative flu hospitalization rate of 80–85 per 100,000 population through week 12 (late March) 2026 at 68% implied probability, aligning closely with the median from CDC FluSurv-NET historical data across moderate seasons since 2010, where rates typically range 70–90 by mid-March amid waning winter peaks. This positioning reflects stable epidemiological baselines, with annual severity driven by influenza strain dominance—often A(H3N2)—vaccine matching, and population immunity levels, rather than short-term anomalies. The ongoing 2024–25 season's hospitalization rate has declined sharply to under 2 per 100,000 weekly (cumulative ~50), marking a mild year consistent with good vaccine efficacy but underscoring yearly variability; no major shifts like novel variants have emerged in recent CDC surveillance to alter 2026 forecasts. Watch for WHO's September 2025 northern hemisphere vaccine strain recommendations, which could signal mismatch risks influencing transmission dynamics.

Trader consensus on Polymarket strongly favors a cumulative flu hospitalization rate of 80–85 per 100,000 population through week 12 (late March) 2026 at 68% implied probability, aligning closely with the median from CDC FluSurv-NET historical data across moderate seasons since 2010, where rates typically range 70–90 by mid-March amid waning winter peaks. This positioning reflects stable epidemiological baselines, with annual severity driven by influenza strain dominance—often A(H3N2)—vaccine matching, and population immunity levels, rather than short-term anomalies. The ongoing 2024–25 season's hospitalization rate has declined sharply to under 2 per 100,000 weekly (cumulative ~50), marking a mild year consistent with good vaccine efficacy but underscoring yearly variability; no major shifts like novel variants have emerged in recent CDC surveillance to alter 2026 forecasts. Watch for WHO's September 2025 northern hemisphere vaccine strain recommendations, which could signal mismatch risks influencing transmission dynamics.

Resumen experimental generado por IA con datos de Polymarket · Actualizado

Cuidado con los enlaces externos.

Preguntas frecuentes

"Flu Hospitalization Rate Week 12, 2026?" es un mercado de predicción en Polymarket con 6 resultados posibles donde los operadores compran y venden acciones según lo que creen que sucederá. El resultado líder actual es "80–85" con 61%, seguido de "85–90" con 24%. Los precios reflejan probabilidades en tiempo real de la comunidad. Por ejemplo, una acción cotizada a 61¢ implica que el mercado colectivamente asigna una probabilidad de 61% a ese resultado. Estas probabilidades cambian continuamente a medida que los operadores reaccionan a nuevos desarrollos. Las acciones del resultado correcto son canjeables por $1 cada una tras la resolución del mercado.

"Flu Hospitalization Rate Week 12, 2026?" es un mercado recién creado en Polymarket, lanzado el Mar 27, 2026. Como mercado nuevo, esta es tu oportunidad de ser uno de los primeros operadores en establecer las probabilidades y las señales de precio iniciales del mercado. También puedes guardar esta página en marcadores para seguir el volumen y la actividad de trading a medida que el mercado gana tracción.

Para operar en "Flu Hospitalization Rate Week 12, 2026?", explora los 6 resultados disponibles en esta página. Cada resultado muestra un precio actual que representa la probabilidad implícita del mercado. Para tomar una posición, selecciona el resultado que consideres más probable, elige "Sí" para operar a favor o "No" para operar en contra, introduce tu cantidad y haz clic en "Operar". Si tu resultado elegido es correcto cuando el mercado se resuelve, tus acciones de "Sí" pagan $1 cada una. Si es incorrecto, pagan $0. También puedes vender tus acciones en cualquier momento antes de la resolución.

El favorito actual para "Flu Hospitalization Rate Week 12, 2026?" es "80–85" con 61%, lo que significa que el mercado asigna una probabilidad de 61% a ese resultado. El siguiente resultado más cercano es "85–90" con 24%. Estas probabilidades se actualizan en tiempo real a medida que los operadores compran y venden acciones. Vuelve con frecuencia o guarda esta página en marcadores.

Las reglas de resolución para "Flu Hospitalization Rate Week 12, 2026?" definen exactamente qué debe ocurrir para que cada resultado sea declarado ganador, incluyendo las fuentes de datos oficiales utilizadas para determinar el resultado. Puedes revisar los criterios de resolución completos en la sección "Reglas" en esta página sobre los comentarios. Recomendamos leer las reglas cuidadosamente antes de operar, ya que especifican las condiciones exactas, casos especiales y fuentes.